couter

AAgilent Technologies, Inc.

Agilent Technologies, Inc. (A) sells diagnostic and life sciences equipment, reagents, and software, with a focus on pharmaceutical and biotech research. The next catalyst is Sep 25, 2026 — If There's a Stock Market Crash Ahead, History Highlights the Best Strategy for…, which will test the company’s resilience in a volatile market environment.

  • Revenue hit $7.25B in 2026, up 6.7% YoY.
  • Free cash flow (TTM) stands at $2.07B, with a net margin of 18.5%.
  • Debt-to-equity ratio of 0.50x, suggesting moderate leverage.
Nov 23, 2026 — Q4 2026 Earnings Release
Chart by TradingView

The schedule

  • Mon23Nov

    Agilent to Join J.P. Morgan Conference Sept. 23 | A Stock News

  • Mon22Feb
  • Mon24May
  • Mon23Aug
  • Thu23Sep

    Agilent to Join J.P. Morgan Conference Sept. 23 | A Stock News

Past

  • Fri25Sep

    Actual outcome: Mixed · $170.59 at outcome

    Price-based classification ($169.79 vs targets).

    If There's a Stock Market Crash Ahead, History Highlights the Best Strategy for…

  • Thu30Apr

    Actual outcome: Bear · $112.74 at outcome

    Price reached or fell below bear floor ($110.00) at outcome date.

    Price reached or fell below bear floor ($110.00) at outcome date.

  • Wed25Feb

    Actual outcome: Bear · $119.04 at outcome

    Agilent reported Q1 results that missed earnings estimates and highlighted significant margin pressure, which overshadowed a 7% increase in revenue. The stock price declined as investors focused on these profitability concerns and operational headwinds, driving the price down toward the bear floor by the run date.

    Agilent reported Q1 results that missed earnings estimates and highlighted significant margin pressure, which overshadowed a 7% increase in revenue. The stock price declined as investors focused on these profitability concerns and operational headwinds, driving the price down toward the bear floor by the run date.

Scouting Reports